610318-54-2
610318-54-2
Chemical Structure
RGX-104
Synonym(s): Abequolixron
- CAS No.: 610318-54-2
- Formula:C34H33ClF3NO3
- Molecular Weight:596.08
IUPAC Name: (R)-2-(3-(3-((2-chloro-3-(trifluoromethyl)benzyl)(2,2-diphenylethyl)amino)butoxy)phenyl)acetic acid
InChIKey: ZLJZDYOBXVOTSA-XMMPIXPASA-N
SMILES: O=C(O)CC1=CC=CC(OCC[C@H](N(CC2=CC=CC(C(F)(F)F)=C2Cl)CC(C3=CC=CC=C3)C4=CC=CC=C4)C)=C1
Biological Activity: RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
RGX-104 | 99.76% | RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
RGX-104 (Standard) | ≥98% | RGX-104 (Standard) is the analytical standard of RGX-104 (HY-111498A). This product is intended for research and analytical applications. RGX-104 is an orally bioavailable and potent liver-X nuclear hormone receptor (LXR) agonist that modulates innate immunity via transcriptional activation of the ApoE gene. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
